Cellectis Romainville (CMVLF, $1.9) was a top loser over the last three months, falling -2 to $1.9 per share. A.I.dvisor analyzed 954 stocks in the Biotechnology Industry for the 3-month period ending May 25, 2023, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. 550 similar cases when CMVLF's price dropped within three months. In out of those 550 cases, CMVLF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for CMVLF are